Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
批准号:
10158949
负责人:
David H Ellison
金额:
$14.93万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-02 至 2022-06-30
关键词:
AddressAdministrative PersonnelAttentionAttitudeAwardBiomedical ResearchBudgetsBusinessesClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesComplexDiseaseEffectivenessEvaluationEventFosteringFunding OpportunitiesFutureGoalsHealth SciencesHome environmentHuman ResourcesInformaticsInstitutesInstitutionInvestmentsKnowledgeLeadLeadershipLearningLocationMaintenanceMeasuresMonitorOregonOutcome MeasurePatient RecruitmentsPeriodicityPersonsPositioning AttributePrincipal InvestigatorProcessQuality ControlReportingResearchResearch InstituteResearch PersonnelResearch SupportResourcesScienceServicesStructureSupport SystemSystemTestingTrainers TrainingTrainingTranslational ResearchUniversitiesclinical carecostimprovedinnovationnext generationprogramsquality assuranceskillssuccesstooltranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon
Health & Science University since 2006. Its many highly functional programs assist investigators and trainees
by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also
become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the
goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in
an ideal state. OCTRI's overall aims are to:
Overall Aim 1: Catalyze Clinical and Translational Research.
Overall Aim 2: Enhance Partnerships with Communities.
Overall Aim 3: Foster and Support Scientific Collaboration.
Overall Aim 4: Expand the Translational Workforce for the 21st Century.
Overall Aim 5: Cultivate Innovation in Research.
We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the
guidance of several advisory groups. We will catalyze research by developing and supporting new informatics
approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the
recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse
stakeholders in the translational research process, by partnering with OHSU investigators, community
coalitions, and business enterprises. We will foster team science through local awards to trainees and to
emerging investigators. We will partner with regional institutions to foster community-engaged research, to
enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other
institutions. We will train clinical and translational scientists and research staff for the next generation, by
focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes
and, when necessary, “turn the curve.”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-004
-
批准号:10198073
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位: